10 Fastest Growing Consumer Stocks to Buy Now
The article lists 10 consumer stocks screened for over 30% annual revenue growth and recent catalysts. It cites Fidelity, Invesco, and BlackRock views on uneven consumer demand. For Rivian (RIVN), UBS raised its price target to $17 and Rivian priced a 75M share secondary at $15.50. For Trip.com (TCOM), analysts cut targets amid antitrust uncertainty; Q1 EPS was RMB5.73 and revenue RMB16.2B.
How this was made
The 30-second read
Why it matters
It provides company-specific catalysts: Rivian’s secondary offering and revenue outlook statement, and Trip.com’s analyst downgrade/target cuts tied to antitrust uncertainty and Q2 guidance.
Market read
Traders can use the disclosed dilution event and the latest sell-side revisions to adjust near-term positioning and risk controls for RIVN and TCOM.
What to watch
The article does not quantify cash use, margin impact, or the probability/timeline of antitrust resolution for Trip.com, which could dominate the stock reaction once more details emerge.
Background
The piece frames consumer discretionary as uneven, with investors favoring companies showing revenue expansion through brand, pricing, digital channels, and market share gains.
Ticker impact
Rivian priced a 75M-share secondary offering at $15.50 and filed an 8-K projecting higher Q2 revenues, plus UBS raised its PT to $17.
Choppy to slightly negative bias on dilution concerns, with support if delivery and revenue growth commentary is viewed as credible.
The article discloses a specific capital raise (secondary offering) and a fresh revenue outlook statement, which can move sentiment in opposite directions.
Trip.com faced multiple analyst target cuts and a downgrade tied to antitrust investigation uncertainty and a weaker-than-expected Q2 outlook.
Downward pressure likely, especially if the market prioritizes the antitrust uncertainty and Q2 outlook reset.
The text provides concrete downgrade/PT changes and cites specific reasons (antitrust resolution lack, weaker Q2 outlook) plus an EPS/revenue print versus consensus.
Market effects
Highlights that consumer growth narratives are increasingly selective, with investors focusing on delivery, pricing, and guidance rather than broad demand recovery.
Trip.com’s antitrust overhang underscores China travel regulatory risk as a factor for international travel-related equities.
Sell-side revisions tied to regulatory uncertainty can spill over to other travel platforms and consumer discretionary growth stocks globally.
Counterpoint
For Rivian, the secondary offering may be interpreted as funding for growth rather than a fundamental deterioration, especially alongside delivery and software/electrical architecture revenue commentary.
Key entities
- companyRivian Automotive, Inc.
Secondary offering priced at $15.50 and an 8-K revenue outlook for the quarter ended June 30, 2026.
- companyTrip.com Group Limited
Analyst downgrade and multiple price target reductions citing antitrust investigation uncertainty and weaker Q2 outlook.
- analyst_firmUBS
Raised Rivian price target to $17 from $16 and kept Neutral.
- analyst_firmChina Renaissance
Downgraded Trip.com to Hold from Buy with a $42 price target.
- analyst_firmBofA
Lowered Trip.com price target to $64 from $78 and kept Buy, citing disappointment and Q2 outlook.
